| Post date: 2021/11/13 |
GoCB samples have been used in a number of national and international research projects, for example the Mutographs project funded by the Cancer Research UK (CRUK) grand challenge program. According to its preliminary findings, two GoCB tissue samples went through standard pipeline for whole genome sequencing of tumor. The quality control steps for data and sample quality suggested that percentage of tumoral cells through using allel-specific copy number analysis were 48% and 60% which are at the level of acceptance for downstream analysis (the average of tumor purity in this multi-center studies is around 42%). The findings also suggested that more than 97% of reads were mappable to human genome without report of contamination.
The GoCB was accepted as a member of the biobank and cohort building network (BCNet) of the International agency for research on cancer (IARC) as of August 2019, and the International society for biological and environmental repositories (ISBER) in January 2020.
The GoCB was accepted as a member of the biobank and cohort building network (BCNet) of the International agency for research on cancer (IARC) as of August 2019, and the International society for biological and environmental repositories (ISBER) in January 2020.
View: 189 Time(s) |
Print: 75 Time(s) |
Email: 0 Time(s) |
0 Comment(s)
© 2025 All Rights Reserved | Golestan Research Center of Gastroenterology & Hepatology
Designed & Developed by : Yektaweb